Literature DB >> 18351692

Contact spotting of protein microarrays coupled with spike-in of normalizer protein permits time-resolved analysis of ERBB receptor signaling.

Christian Löbke1, Mark Laible, Claudia Rappl, Markus Ruschhaupt, Ozgür Sahin, Dorit Arlt, Stefan Wiemann, Annemarie Poustka, Holger Sültmann, Ulrike Korf.   

Abstract

Protein microarrays allow highly accurate comparison and quantification of numerous biological samples in parallel while requiring only little material. This qualifies protein arrays for systems biology and clinical research where only limited sample material is available, but a precise readout is required. With the introduction of signal normalization steps to monitor the drop size of manually contact-spotted RP protein arrays, the usefulness of normalizer proteins to ensure a high-throughput but inexpensive protein analysis was demonstrated. This approach was applied for the analysis of signaling through ERBB receptor activated kinases in the breast cancer cell line MCF-7. Activation of ERK1/2 and AKT by ERBB1 (EGFR), ERRB2 (HER2/neu), and ERBB3-4 was monitored in a time-resolved manner. Analysis of pathway activation by stimulation with epidermal growth factor and heregulin, or inhibition by blocking with gefitinib or herceptin allowed a characterization of the distinct signaling properties of the different ERBB receptor subtypes.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18351692     DOI: 10.1002/pmic.200700733

Source DB:  PubMed          Journal:  Proteomics        ISSN: 1615-9853            Impact factor:   3.984


  6 in total

1.  Biomarker discovery and clinical proteomics.

Authors:  Jerzy Silberring; Pawel Ciborowski
Journal:  Trends Analyt Chem       Date:  2010-02-01       Impact factor: 12.296

Review 2.  Reverse phase protein microarrays advance to use in clinical trials.

Authors:  Claudius Mueller; Lance A Liotta; Virginia Espina
Journal:  Mol Oncol       Date:  2010-10-16       Impact factor: 6.603

3.  Increasing the sensitivity of reverse phase protein arrays by antibody-mediated signal amplification.

Authors:  Jan C Brase; Heiko Mannsperger; Holger Fröhlich; Stephan Gade; Christian Schmidt; Stefan Wiemann; Tim Beissbarth; Thorsten Schlomm; Holger Sültmann; Ulrike Korf
Journal:  Proteome Sci       Date:  2010-06-22       Impact factor: 2.480

4.  Targeted therapies in cancer - challenges and chances offered by newly developed techniques for protein analysis in clinical tissues.

Authors:  K Malinowsky; C Wolff; S Gündisch; D Berg; Kf Becker
Journal:  J Cancer       Date:  2010-12-19       Impact factor: 4.207

Review 5.  Facing current quantification challenges in protein microarrays.

Authors:  Robert Wellhausen; Harald Seitz
Journal:  J Biomed Biotechnol       Date:  2012-04-24

Review 6.  Proteomic strategies for the discovery of novel diagnostic and therapeutic targets for infectious diseases.

Authors:  Moushimi Amaya; Alan Baer; Kelsey Voss; Catherine Campbell; Claudius Mueller; Charles Bailey; Kylene Kehn-Hall; Emanuel Petricoin; Aarthi Narayanan
Journal:  Pathog Dis       Date:  2014-03-13       Impact factor: 3.166

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.